← Browse by Condition
Medical Condition
sleep wake disorders
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT06701396 Phase 3
Recruiting
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Vanda Pharmaceuticals
NCT04214184
Recruiting
Biomarkers of Increased Free Living Sleep Time
Enrollment
46 pts
Location
United States
Sponsor
University of Utah